Official registry condition

Nocturia peptide trials

9 selected ClinicalTrials.gov records carrying the official condition label Nocturia. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

9 selected records.

Connected peptides

1 profiles.

Registry update years

2009–2022 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles1

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 25 selected PubMed records and 38 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Nocturia unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00902655

PeptideScanner retained ClinicalTrials.gov record NCT00902655 at 2026-11-16T01:33:21.554Z. Its registry update date was 2009-05-15, and PeptideScanner's reviewed identity mapping was desmopressin.

PeptideScanner change date
November 16, 2026
Cited source date
May 15, 2009
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01184859

PeptideScanner retained ClinicalTrials.gov record NCT01184859 at 2026-11-16T01:33:21.554Z. Its registry update date was 2012-05-25, and PeptideScanner's reviewed identity mapping was desmopressin.

PeptideScanner change date
November 16, 2026
Cited source date
May 25, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01223937

PeptideScanner retained ClinicalTrials.gov record NCT01223937 at 2026-11-16T01:33:21.554Z. Its registry update date was 2015-10-15, and PeptideScanner's reviewed identity mapping was desmopressin.

PeptideScanner change date
November 16, 2026
Cited source date
October 15, 2015
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →